Skip to main content

Table 1 The baseline data of the patients with CAP

From: Efficacy of the quick sequential organ failure assessment for predicting clinical outcomes among community-acquired pneumonia patients presenting in the emergency department

Characteristics ICU
(n = 174)
Non-ICU
(n = 568)
P ARDS
(n = 164)
Non-ARDS (n = 578) P Survivor
(n = 443)
Non-Survivors (n = 299) P
Age, years 70.40 ± 13.46 68.60 ± 13.74 0.128 70.26 ± 14.19 68.67 ± 13.53 0.189 68.23 ± 13.50 70.19 ± 13.90 0.055
Male, % 106 (60.92) 356 (62.68) 0.676 100 (60.98) 362 (62.63) 0.670 268 (60.50) 194 (64.88) 0.227
COPD, % 56 (32.18) 121 (21.30) 0.003 46 (28.05) 131 (22.66) 0.153 90 (20.32) 87 (29.10) 0.006
CVD, % 39 (22.41) 91 (16.02) 0.052 34 (20.73) 96 (16.61) 0.220 78 (17.61) 52 (17.39) 0.940
Hypertension, % 89 (51.15) 254 (44.72) 0.137 79 (48.17) 264 (45.67) 0.572 205 (46.28) 138 (46.15) 0.974
DM, % 68 (39.08) 190 (33.45) 0.173 65 (39.63) 193 (33.39) 0.138 136 (30.70) 122 (40.80) 0.005
CHF, % 86 (49.43) 236 (41.55) 0.067 72 (43.90) 250 (43.25) 0.882 180 (40.63) 142 (47.49) 0.064
CRD, % 27 (15.52) 57 (10.04) 0.046 20 (12.20) 64 (11.07) 0.689 46 (10.38) 38 (12.71) 0.327
Tumor, % 23 (13.22) 55 (9.68) 0.183 24 (14.63) 54 (9.34) 0.051 35 (7.90) 43 (14.38) 0.005
MBP, mmHg 81.91 ± 24.19 92.33 ± 18.88 < 0.001 82.34 ± 23.99 92.02 ± 19.16 < 0.001 92.15 ± 19.83 86.53 ± 21.54 < 0.001
Respiratory rate, beats/min 31.95 ± 7.33 29.72 ± 6.46 < 0.001 32.15 ± 8.30 29.70 ± 6.13 < 0.001 29.91 ± 6.27 30.74 ± 7.37 0.110
Temperature, °C 37.48 ± 1.30 37.41 ± 1.13 0.535 37.69 ± 1.36 37.35 ± 1.10 0.004 37.46 ± 1.14 37.37 ± 1.22 0.305
Heart rate, beats/min 78.11 ± 21.31 107.20 ± 31.20 < 0.001 116.60 ± 21.69 111.70 ± 29.41 0.079 109.30 ± 21.25 115.00 ± 29.64 0.002
PaO2, mmHg 73.54 ± 34.78 84.15 ± 31.45 < 0.001 66.49 ± 29.17 85.97 ± 32.19 < 0.001 81.92 ± 28.89 81.29 ± 37.37 0.804
Lac, mmol/L 4.47 ± 3.69 2.07 ± 2.05 < 0.001 2.60 (1.50,5.05) 1.50 (0.90,2.50) < 0.001 1.50 (1.00,2.40) 2.00 (1.10,4.20) < 0.001
PCT, ng/mL 1.50 (0.28,8.50) 0.28 (0.06,1.75) < 0.001 1.62 (0.35,9.53) 0.27 (0.06,1.68) < 0.001 0.24 (0.06,1.44) 1.06 (0.16,6.16) < 0.001
WBC, ×109/L 12.77 (8.23,18.97) 11.22 (7.99,15.66) < 0.001 12.70 (7.73,17.67) 11.34 (8.11,15.88) 0.229 12.30 (8.38,16.82) 12.30 (7.80,15.88) 0.111
PaO2/FiO2 199.70 ± 105.10 246.20 ± 104.50 < 0.001 165.40 ± 71.61 255.20 ± 4.42 < 0.001 239.08 ± 96.05 229.76 ± 120.05 0.262
CRP 42.39 ± 5.25 41.59 ± 5.06 0.037 43.09 ± 5.30 41.58 ± 5.06 < 0.001 41.59 ± 5.06 42.39 ± 5.25 0.037
qSOFA score 1.96 ± 0.76 1.35 ± 0.62 < 0.001 1.98 ± 0.70 1.36 ± 0.64 < 0.001 1.38 ± 0.63 1.66 ± 0.77 < 0.001
SOFA score 9.58 ± 5.11 5.38 ± 4.18 < 0.001 9.21 ± 4.85 5.56 ± 4.41 < 0.001 5.66 ± 4.08 7.40 ± 5.45 < 0.001
CURB-65 score 3.16 ± 1.23 2.19 ± 1.19 < 0.001 3.29 ± 1.17 2.17 ± 1.18 < 0.001 2.22 ± 1.20 2.71 ± 1.30 < 0.001
  1. COPD chronic obstructive pulmonary disease, CVD Cerebrovascular disease, DM Diabetes mellitus, CHF chronic heart failure, CRD chronic renal dysfunction, MBP myelin basic protein, Lac lactate, PCT: p rocalcitonin, WBC white blood cell, CRP C-reactive protein, qSOFA quick sequential organ failure assessment, SOFA sequential organ failure assessment, CURB-65 confusion, urea, respiratory rate, blood pressure and age